ストックスクリーナーアプリを入手
1.01
0.00%
0.00
アフターアワーズ：
1.01
前日終値:
$1.01
開ける：
$1.04
24時間の取引高:
279.95K
Relative Volume:
0.58
時価総額：
$47.50M
収益：
-
当期純損益:
$-40.56M
株価収益率:
-0.8632
EPS:
-1.17
ネットキャッシュフロー:
$-35.28M
1週間 パフォーマンス:
-3.81%
1か月 パフォーマンス:
-18.55%
6か月 パフォーマンス:
-15.13%
1年 パフォーマンス:
-73.56%
1日の値動き範囲:
$1.00
$1.04
1週間の範囲:
$1.00
$1.08
52週間の値動き範囲:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
名前
Pds Biotechnology Corporation
セクター
電話
800-208-3343
住所
303A COLLEGE ROAD EAST, PRINCETON
PDSB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.01 | 47.50M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-01 | 開始されました | B. Riley Securities | Buy |
| 2021-06-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-10 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | 開始されました | Alliance Global Partners | Buy |
| 2020-03-09 | 開始されました | Noble Capital Markets | Outperform |
| 2019-10-24 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Pds Biotechnology Corporation (PDSB) 最新ニュース
What’s the recovery path for long term holders of PDS Biotechnology CorporationJuly 2025 Levels & Real-Time Stock Entry Alerts - newser.com
Is PDS Biotechnology Corporation stock undervalued vs historical averagesJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - newser.com
How to integrate PDS Biotechnology Corporation into portfolio analysis toolsQuarterly Investment Review & Real-Time Market Sentiment Alerts - newser.com
Is PDS Biotechnology Corporation stock a safe investment in uncertain marketsJuly 2025 Trade Ideas & Fast Gaining Stock Reports - newser.com
Momentum divergence signals in PDS Biotechnology Corporation chartEarnings Trend Report & Weekly High Return Forecasts - newser.com
Using data filters to optimize entry into PDS Biotechnology CorporationWeekly Trade Report & Entry Point Confirmation Alerts - newser.com
What technical models suggest about PDS Biotechnology Corporation’s comebackJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - newser.com
Key resistance and support levels for PDS Biotechnology Corporation2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
What valuation multiples suggest for PDS Biotechnology Corporation stockQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
PDS Biotechnology Reports Promising Phase 2 Trial Results - MSN
Applying Elliott Wave Theory to PDS Biotechnology CorporationTrade Exit Summary & Safe Capital Growth Tips - newser.com
Critical Comparison: PDS Biotechnology (NASDAQ:PDSB) and Femasys (NASDAQ:FEMY) - Defense World
Custom strategy builders for tracking PDS Biotechnology CorporationIPO Watch & Target Return Focused Picks - newser.com
Published on: 2025-09-19 23:06:32 - newser.com
PDS Biotechnology Corporation stock volume spike explained2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Using portfolio simulators with PDS Biotechnology Corporation includedPortfolio Update Report & Technical Confirmation Alerts - newser.com
Pattern recognition hints at PDS Biotechnology Corporation upside2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com
Volatility clustering patterns for PDS Biotechnology CorporationPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-09-19 03:12:27 - خودرو بانک
Chart based exit strategy for PDS Biotechnology CorporationJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
PDS Biotech reports 29.5-month survival in head and neck cancer trial - Investing.com Australia
PDS Biotech Sets Significant Benchmark in Head and Neck - GlobeNewswire
29.5-Month Survival Breakthrough: PDS Biotech's Cancer Drug Shows Nearly 3x Better Results Than Current Treatment - Stock Titan
Market Review: Can OSR Holdings Inc Equity Warrant continue delivering strong returnsMarket Performance Summary & Free Daily Entry Point Trade Alerts - khodrobank.com
Pds Biotechnology Corporation (PDSB) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):